Arctic Bioscience AS
OSE:ABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jwipc Technology Co Ltd
SZSE:001339
|
CN |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Vita 34 AG
XETRA:V3V
|
DE |
|
Controladora Vuela Compania de Aviacion SAB de CV
NYSE:VLRS
|
MX |
Arctic Bioscience AS
Interest Expense
Arctic Bioscience AS
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Arctic Bioscience AS
OSE:ABS
|
Interest Expense
kr3.1m
|
CAGR 3-Years
110%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Interest Expense
kr126k
|
CAGR 3-Years
216%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Circio Holding ASA
OSE:CRNA
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arctic Bioscience AS
Glance View
Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The firm's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
See Also
What is Arctic Bioscience AS's Interest Expense?
Interest Expense
3.1m
NOK
Based on the financial report for Dec 31, 2024, Arctic Bioscience AS's Interest Expense amounts to 3.1m NOK.
What is Arctic Bioscience AS's Interest Expense growth rate?
Interest Expense CAGR 5Y
46%
Over the last year, the Interest Expense growth was 217%. The average annual Interest Expense growth rates for Arctic Bioscience AS have been 110% over the past three years , 46% over the past five years .
